| Prev Close | 221.90 |
| Day Low/High | 212.69 / 218.92 |
| 52 Wk Low/High | 124.54 / 227.39 |
Stryker Corporation (SYK)
214.74
NYSE
| Exchange | NYSE |
| Shares Outstanding | 375.61B |
| Market Cap | 83.35B |
| P/E Ratio | 52.71 |
| Div & Yield | N.A. (N.A) |
Latest News
Trading Volumes Rising, GDP Forecasts, Earnings and Trading Thoughts
Market leadership may be lacking on Thursday despite rising trading volumes, plus an update on Apple, Microsoft, Mastercard, Amazon and Gilead.
6 Testing, Diagnostics and Medical Devices Stocks You Should Know About
Look for weaknesses in companies like these that can provide solutions to today's pressing issues.
Stryker Shares Could Continue to Struggle in the Weeks Ahead
The stock of the medical device maker has been stagnant for months and its charts have yet to prove themselves.
6 Market Winds of Change, Trading Beyond Meat, GrubHub Earnings: Market Recon
If there was not a sizable addressable market for Beyond Meat, the competition would not be building as quickly as it is.
7 Medical Products Stocks With the Right Prescription for Gains
Top picks in the fast-growing medical products market.
SOX It to Me, Military Mischief in Asia, and Awaiting Amazon: Market Recon
And as the semiconductor sector continues to shine, Brooks Automation is a name to keep in mind.
Coming Up Short? Here Are Some Stocks to Consider
To effectively generate profits, a trader must pick several companies in a sector and short the whole bunch.
Early Morning Upgrades and Downgrades
Upgrades Dova Pharmaceuticals  upgraded to Outperform from In-line at Evercore ISI Meridian Bancorp  upgraded to Overweight from Neutral at Piper Jaffray; price target raised to $20 Landstar System  upgraded to Mkt Perform from Underperform at Raymo...
The FANGs Ride Again, Plus Mercury Systems Rising: Market Recon
Netflix led the charge in FANG names. And why MRCY is now a hot stock in the defense sector.
Sloppy Earnings, China's Economy, AMD Earnings Preview: Market Recon
What we have seen of late from a number of chip producers really might be interpreted as pre-recessionary.
Stryker Is a Stock to Avoid Right Now
If you currently hold Stryker shares, consider selling and swapping into much better values.
Here Are 9 Takeaways From Last Night's Meltdown: Market Recon
It becomes difficult for me to tell you where to run in these markets...
3 Ways to Play Facebook Ahead of Wednesday's Earnings
Here are some options strategies for this FANG name into tomorrow's report.
Closing Bell: LIVE MARKETS BLOG
The major U.S. averages closed the day in the green Monday.
Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back
The crash of oil will only accelerate the move.
4 Keys to Staying Alive in Tough Markets -- And How I'm Playing 3 Big Tech Names
KLA-Tencor, Microsoft and Intel all report earnings after the close Thursday.
Jim Cramer: We've Got a Battle Ahead of Us, But the Fed Might Resolve It
Sectors are saying different things about rates, but new Fed chief Jerome Powell could provide clarity at his first press conference on Wednesday.
Stocks Need to Move Lower to Be Able to Move Higher Again: Market Recon
You might actually be grateful that stocks took one on the jaw on Monday.
Remember That Bumps in the Road Are Normal: Market Recon
The forces that artificially impacted the marketplace return to normal; so will the marketplace itself.
These Stocks Are Ready to Reverse Course
This week's bullish and bearish reversal patterns.
Don't Get Out of Joint
Demand for artificial joints is growing, and Zimmer Biomet is a good way to play the demographic trend.
Cramer: There Are Powerful Themes in Several Bull Markets
It's a wonder to me how split this market really is.
Cramer: We Have Nothing to Distinguish the Stocks Right Now
We know that we are in the era when index managers are ascendant.
Cramer: Top 10 Bull Markets Right Now
Bull market number one, perhaps of all time: the financials.
Cramer: Money's Being Thrown at Almost Everything in the Market
There are nearly too many surging sectors to count.
After Fits and Starts, Stryker Should Move Much Higher
A one-day pullback wouldn't turn me into a bear.
Jim Cramer Says Don't Trade Stocks Based on Trump Cabinet Nominations
Investors shouldn't be buying certain healthcare stocks based on Donald Trump's nomination of Tom Price as HHS chief, says Jim Cramer.
Stryker Should Soon Resume Its Uptrend
A rising daily OBV line makes me bullish on the next move for SYK.
